Dynamk Capital
North America, New York, United States, New York
Description
Venture fund focused entirely on Life Sciences Industrials - tools, technologies and services fundamental to biopharma.
Investor Profile
Dynamk Capital has backed more than 19 startups, with 0 new investments in the last 12 months alone. The firm has led 14 rounds, about 74% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in United States, Norway, Canada.
- Strong thematic focus on Biotechnology, Medical, Life Science.
Stage Focus
- Series A (58%)
- Seed (21%)
- Series B (16%)
- Series Unknown (5%)
Country Focus
- United States (84%)
- Norway (5%)
- Canada (5%)
- Switzerland (5%)
Industry Focus
- Biotechnology
- Medical
- Life Science
- Health Care
- Artificial Intelligence (Ai)
- Therapeutics
- Manufacturing
- Medical Device
- Bioinformatics
- Machine Learning
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
